prediabetes and new-onset diabetes. As a basic characteristic of type 2 diabetes mellitus (T2DM), insulin resistance plays an important role in the development and progression of arteriosclerosis. Insulin resistance is present in prediabetes, and populations
Page:12
Early arteriosclerosis and its risk factors in subjects with prediabetes and new-onset diabetes
Xiaoli Liu, Lanxiang Liu, Rui Wang, Xiaojiao Jia, Binbin Liu, Ning Ma, and Qiang Lu
Pancreatic and gut hormones as predictors of new-onset prediabetes after non-necrotising acute pancreatitis: a prospective longitudinal cohort study
Sakina H Bharmal, Wandia Kimita, Juyeon Ko, and Maxim S Petrov
from several studies suggests that individuals with AP are at a two-times increased risk of new-onset diabetes than the general population, independent of the severity of AP ( 5 , 6 , 7 ). Given that the cumulative incidence of new-onset diabetes
Simvastatin profoundly impairs energy metabolism in primary human muscle cells
Selina Mäkinen, Neeta Datta, Yen H Nguyen, Petro Kyrylenko, Markku Laakso, and Heikki A Koistinen
in patients with type 2 diabetes ( 8 ). Regarding individual statins, simvastatin or rosuvastatin use was associated with the highest risk for type 2 diabetes, whereas pravastatin use was associated with low risk of new-onset diabetes ( 9 ). Statins
Effect of plasma glucose at admission on COVID-19 mortality: experience from a tertiary hospital
Bharat Kumar, Madhukar Mittal, Maya Gopalakrishnan, Mahendra K Garg, and Sanjeev Misra
Rani CS Jeba Rani S Gupta R Jha A Gupta V Kuchay MS Luthra A Durrani S et al . Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic
The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
Thozhukat Sathyapalan, Anne-Marie Coady, Eric S Kilpatrick, and Stephen L Atkin
-analysis . Diabetes Care 2009 32 1924 – 1929 . ( doi:10.2337/dbib9-0738 ) 19794004 10.2337/dc09-0738 5 Waters DD Ho JE DeMicco DA Breazna A Arsenault BJ Wun CC Kastelein JJ Colhoun H Barter P. Predictors of new-onset
Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients
Vita Birzniece, Teresa Lam, Mark McLean, Navneeta Reddy, Haleh Shahidipour, Amy Hayden, Howard Gurney, Glenn Stone, Rikke Hjortebjerg, and Jan Frystyk
controls ( 3 ). Insulin resistance is increased by more than 30% as early as 3 months after the initiation of ADT ( 4 ), and the risk of new-onset diabetes is increased four- to five-fold in the first year of treatment ( 5 ). These conditions are known to
Autoimmune thyroid disease correlates to islet autoimmunity on zinc transporter 8 autoantibody
Yun Cai, Jieni Yan, Yong Gu, Heng Chen, Yang Chen, Xinyu Xu, Mei Zhang, Liping Yu, Xuqin Zheng, and Tao Yang
non-obese adults with new-onset diabetes? European Journal of Endocrinology 2014 170 651 – 658 . ( https://doi.org/10.1530/EJE-13-0901 ) 26 Gu Y Zhang M Chen H Wang Z Xing C Yang H Xu X Liu Y Zhou Z Yu L Discordant
Endocrine toxicity of cancer immunotherapy: clinical challenges
Bliss Anderson and Daniel L Morganstein
) Usually 1–3 months after treatment Hyperglycaemia and new-onset diabetes Approximately 1% (59) Anti-PD-1/PD-L1 (58, 61, 62) Polydipsia, polyuria, weight loss Hyperglycaemia on fasting and random glucose samples, HbA1c Persistent
Novel therapies for acromegaly
Bernardo Maia, Leandro Kasuki, and Mônica R Gadelha
Pasireotide + Pegvisomant (38) Somatostatin receptor ligand + GHR antagonist Phase 4 Pasireotide 60 mg IM monthly + Pegvisomant 21-78 mg SC weekly 73.8 NA Hyperglycemia, new-onset diabetes, gastrointestinal, myalgia, fatigue, headache, arthralgia
Early and late endocrine complications of COVID-19
Paraskevi Kazakou, Stavroula A Paschou, Theodora Psaltopoulou, Maria Gavriatopoulou, Eleni Korompoki, Katerina Stefanaki, Fotini Kanouta, Georgia N Kassi, Meletios-Athanasios Dimopoulos, and Asimina Mitrakou
. Emerging Infectious Diseases 2020 26 1618 – 1620 . ( https://doi.org/10.3201/eid2607.200445 ) 38 Rubino F Amiel SA Zimmet P Alberti G Bornstein S Eckel RH Mingrone G Boehm B Cooper ME Chai Z New-onset diabetes in Covid-19 . New
Page:12
